November 20th 2024
Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery. The results support a regulatory submission, with potential to revolutionize sedation practices in various medical specialties.
High-definition aberrometer represents state of the art for performing wavefront-guided LASIK
November 9th 2017Wavefront-guided LASIK using the iDESIGN Advanced WaveScan Studio System, STAR S4 IR Excimer Laser System, and the iFS Laser (all from J&J Vision), is providing unsurpassed outcomes for the treatment of myopia, hyperopia, and mixed astigmatism, according to Jay S. Pepose, MD, PhD.
Read More
Premium performer: Phacoemulsification unit designed for enhanced safety and efficiency
November 9th 2017The WhiteStar Signature Pro (J&J Vision) offers a diverse range of novel technologies that blend together to make cataract surgery easier, safer, and more efficient, according to Steven H. Dewey, MD.
Read More
Identifying, managing dysphotopsia after cataract surgery
April 25th 2014Following cataract surgery, patients can present with a variety of visual complaints that interfere with vision after IOL implantation. Negative dysphotopsias are relative and absolute scotomas, according toJack T. Holladay, MD.
Read More